Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Breast NeoplasmsOsteoporosis
Interventions
DRUG

Zoledronic Acid

Participants received Zoledronate 4 mg IV 15-minute infusion every 6 months.

DRUG

Letrozole

Participants received Letrozole 2.5 mg daily.

Trial Locations (44)

11235

Hemoncare PC, Brooklyn

15213

University of Pittsburgh Cancer Institute/Magee Womens Hospital, Pittsburgh

21701

Frederick Memorial Hospital Regional Cancer Therapy Center, Frederick

22031

Northern Virginia Oncology Group, Fairfax

23294

Virginia Physicians, Inc.- Oncology, Richmond

29403

Charleston Hematology Oncology, Charleston

32605

Robert R. Carroll, MD, PA, Gainesville

32796

Space Coast Medical, Titusville

33176

Oncology Hematology Group of South Florida, Miami

33324

Cancer Research Network, Inc., Plantation

33479

Ocala Oncology Center, Ocala

33607

Bay Area Oncology, Tampa

34613

FL Community Cancer Center, Brooksville

34652

Pasco Pinellas Cancer Center, New Port Richey

37203

The Sarah Cannon Cancer Center, Nashville

40202

Kentuckiana Cancer Institute, Louisville

44718

Nashat Y. Gabrail MD Inc., Canton

45238

Oncology Partners Network, Cincinnati

Physician Associates, Inc., Cincinnati

45420

Dayton Clinical Oncology Program, Dayton

49503

Cook Research Department at Spectrum Health, Grand Rapids

55416

Metro Minnesota CCOP, Saint Louis Park

58501

Odyssey Research Services, Bismarck

59101

Hematology-Oncology Centers of the Northern Rockies, PC, Billings

60126

Elmhurst Memorial Hospital, Elhurst

68114

Methodist Cancer Center, Omaha

70506

Louisiana Oncology Associates, Lafayette

72764

Highlands Oncology Group, Springdale

75230

Center for Oncology Research & Tx. PA, Dallas

77802

St. Joseph Regional Cancer Center, Bryan

78412

Cancer Specialists of South Texas, Corpus Christi

87109

New Mexico Oncology Hematology, Ltd., Albuquerque

90640

Clinical Trials & Research Associates, Inc., Montebello

90813

Pacific Shores Medical Group, Long Beach

91505

East Valley Hematology & Oncology, Burbank

91750

Wilshire Oncology Medical Group, LaVerne

92270

Cancer and Blood Institute of the Desert, Rancho Mirage

95403

Redwood Regional Medical Group, Santa Rosa

98122

Swedish Cancer Institute, Seattle

99220

Rockwood Clinic, PS, Spokane

06360

Eastern Connecticut Hematology/Oncology Associates, Norwich

02481

New England Hematology/Oncology Associates, Wellesley

07962

Hematology-Oncology Associates of Northern NJ, Morristown

00927

VA Medical Center, San Juan

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY